Frontiers in the treatment of glioblastoma: Past, present and emerging-Reference-Cited by-同舟云学术

Frontiers in the treatment of glioblastoma: Past, present and emerging

Published:2021-04 Issue: Volume:171 Page:108-138
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Janjua Taskeen Iqbal,Rewatkar Prarthana,Ahmed-Cox Aria,Saeed Iqira,Mansfeld Friederike M.,Kulshreshtha Ritu,Kumeria Tushar,Ziegler David S.,Kavallaris Maria,Mazzieri Roberta,Popat Amirali

Funder

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference421 articles.

1. A clinical review of treatment outcomes in glioblastoma multiforme—the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?;Rock;Br. J. Radiol.,2012

2. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment;Hanif;Asian Pac. J. Cancer Prev.,2017

3. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011;Ostrom;Neuro. Oncol.,2014

4. Glioblastoma multiforme: pathogenesis and treatment;Alifieris;Pharmacol. Ther.,2015

5. Glioblastoma: overview of disease and treatment;Davis;Clin. J. Oncol. Nurs.,2016

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways;Non-coding RNA Research;2024-12

2. The potential of exosomes as a new therapeutic strategy for glioblastoma;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

3. Pluronic F127‐Complexed PEGylated Poly(glutamic acid)‐Cisplatin Nanomedicine for Enhanced Glioblastoma Therapy;Macromolecular Rapid Communications;2024-09-12

4. Stimuli-Responsive Polymeric Nanocarriers Accelerate On-Demand Drug Release to Combat Glioblastoma;Biomacromolecules;2024-09-11

5. Integrated MRI radiomics, tumor microenvironment, and clinical risk factors for improving survival prediction in patients with glioblastomas;Strahlentherapie und Onkologie;2024-09-09